Previous Close | 1.05 |
1-Year Change | -77.22% |
6-Months Change | -57.66% |
3-Months Change | -35.19% |
Moving Avg (50d) | 1.4199 |
Moving Avg (200d) | 2.0127 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 121.0M |
Beta (3-Years) | 1.66 |
Revenue Growth (ttm) | 69.37% |
Net Profit Margin (ttm) | -9.52% |
Return On Assets (ttm) | -4.35% |
EPS (ttm) | -0.43 |
PE Ratio (ttm) | -2.44 |
Dividend Yield | % |
Asset Description: | Coherus BioSciences, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Strong sell |
Forecast Date: | 2024-09-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.071 | 1.102 | 1.123 | 1.155 | 1.207 | 1.26 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |